AGP Executive Report
Last update: 10 hours agoSwiss Cybersecurity: A new study with Lucerne University finds many Swiss SMEs underestimate cyber risks, even though incidents can hit liquidity and survival. Life Sciences & Medtech: Pharvaris-backed real-world research on hereditary angioedema highlights gaps between guideline care and patient experience, while CSL’s deal with Alentis adds momentum for rare kidney and liver therapies. Healthcare Manufacturing: Azerbaijan opened a $114m pharma plant aimed at reducing import dependence—another signal of pharma supply-chain reshoring. Finance & Risk: Markets are watching European sovereign stress, with the French-German bond spread widening sharply and investors turning to safer havens like the Swiss franc. Swiss Business Deals: DWS plans to buy Peakside Capital Advisors, expanding its alternatives real estate push across Germany and Central/Eastern Europe. Trade & Industry Links: India and Switzerland signed a migration and mobility pact and agreed to deepen cooperation on AI, defence production and nuclear energy, tied to the TEPA framework. Digital Trust: SGS bought Prescient Security to strengthen cybersecurity and compliance services. Food & Consumer: Emmi Caffè Latte expands in the UK with matcha and vanilla variants.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
